Ryan Allway September 9th, 2021 News, Top Story For all of the talk about cannabis as a medicine and potential treatment for a wide variety of ailments, from sleep to stress to pain disorders and more, there is a huge missing element. There are almost no FDA-approved cannabis-derived medicines.... Read more
Ryan Allway September 7th, 2021 TEL AVIV, Israel, Sept. 7, 2021 /PRNewswire/ — SciSparc Ltd. (OTC Pink: SPRCF), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company”), today announced it has been awarded two patents from the Australian Patent... Read more
Makenzie Branch April 15th, 2021 App, Exclusive, Psychedelics, Top Story Every year, thousands of molecules are being created, synthesized and tested as drug candidates for a vast number of ailments. MagicMed Industries brings this pharmaceutical development approach to the field of psychedelics to create new therapeutic alternatives for patients... Read more
Ryan Allway March 12th, 2021 German, Psychedelics Die Psybrary™ von MagicMed ist eine bemerkenswerte und beeindruckende Leistung, die mehr als geschätzten 125 Millionen Derivaten bis zu deren Patenterteilung Patentschutz bieten könnte. Während 125 Millionen Derivate eine große Zahl ist, sollten dabei zwei Dinge klargestellt werden. Erstens bedeutet diese Zahl... Read more
Ash Stringer August 14th, 2019 App, Exclusive, News, Top Story When you’ve got something great, it may take a little bit of time for people to learn about it, but once word starts getting around, it can yield a windfall of interest. That’s the case with Lexaria Bioscience Corp.... Read more